Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody, R&D Systems™

CD30/TNFRSF8

Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready

Monoclonal

Supernatant

Human

CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8

Human CD30/TNFRSF8

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.

Hu8

Flow Cytometry, CyTOF

Unconjugated

Human

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.

943

IgG1

Protein A or G purified from cell culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.